Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: The analysis of the Czech National Cancer Registry

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Pavlík, Tomáš ^a   Májek, Ondřej ^a   Mužík, Jan ^a   Koptíková, Jana ^a   Slavíček, Lubomír ^a,b   Fínek, Jindřich ^a,c   Feltl, David ^d   Vyzula, Rostislav ^a,e   Dušek, Ladislav ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b Hospital in Jihlava   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^e MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COLORECTAL TUMOR; CZECH REPUBLIC; FEMALE; FORECASTING; HUMAN; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; REGISTER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; CZECH REPUBLIC; FEMALE; FORECASTING; HUMANS; INFANT; MALE; MIDDLE AGED; REGISTRIES; YOUNG ADULT;

EID: 84856797074     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-117     Document Type: Article

References (41)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 Lyon: International Agency for Research on Cancer 2010 Available from: http://globocan.iarc.fr
2. Epidemiology of Malignant Tumours in the Czech Republic. Duek L, Muík J, Kubásek M, Koptíková J, aloudík J, Vyzula R, http://www.svod.cz/
3. Measuring prevalence in Europe: the EUROPREVAL project. Capocaccia R, Colonna M, Corazziari I, De Angelis R, Francisci S, Micheli A, Mugno E, Ann Oncol 2002 13 831 839 10.1093/annonc/mdf152 12123329 (Pubitemid 34752679)
4. Obtaining long-term disease specific costs of care: application to Medicare enrolees diagnosed with colorectal cancer. Brown ML, Riley GF, Potosky AL, Etzioni RD, Med Care 1999 37 1249 1259 10.1097/00005650-199912000-00008 10599606
5. Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000-2020. Mariotto AB, Yabroff KR, Feuer EJ, De Angelis R, Brown M, Cancer Causes Control 2006 17 1215 1226 10.1007/s10552-006-0072-0 17111252 (Pubitemid 44772821)
6. Colon cancer prevalence and estimation of differing care needs of colon cancer patients. Gatta G, Capocaccia R, Berrino F, Ruzza MR, Contiero P, Ann Oncol 2004 15 1136 1142 10.1093/annonc/mdh234 15205210 (Pubitemid 39099117)
7. Prevalence of patients with colorectal cancer requiring follow-up or active treatment. Chauvenet M, Lepage C, Jooste V, Cottet V, Faivre J, Bouvier AM, Eur J Cancer 2009 45 1460 1465 10.1016/j.ejca.2009.01.012 19216071
8. World Health Organization, ICD-O: International Classification of Diseases for Oncology. 3rd revision. Geneva 1995
9. Estimating the completeness of prevalence based on cancer registry data. Capocaccia R, De Angelis R, Stat Med 1997 16 425 440 10.1002/(SICI)1097- 0258(19970228)16:4<425::AID-SIM414>3.0.CO;2-Z 9044530 (Pubitemid 27073011)
10. Demographic data of the Czech Republic and Death Records Database of the Czech Republic. Czech Statistical Office, http://www.czso.cz/eng/redakce.nsf/i/ population
11. Hermanek P, Sobin LH: International Union Against Cancer (UICC): TNM Classification of Malignant Tumors Berlin: Springer 4 1992
12. Binding instructions of the National Health Information System (NHIS), Czech National Cancer Registry-instruction for the contents of data structure, version 051-20060101/2 Institute of Health Information and Statistics of the Czech Republic (IHIS), Prague 2006 Available from: http://www.uzis.cz, section IHIS, part Binding instructions
13. Predicting the future burden of cancer. Bray F, Møller B, Nat Rev Cancer 2006 6 63 74 10.1038/nrc1781 16372017 (Pubitemid 43053652)
14. Comparison of different approaches to incidence prediction based on simple interpolation techniques. Dyba T, Hakulinen T, Stat Med 2000 19 1741 1752 10.1002/1097-0258(20000715)19:13<1741::AID-SIM496>3.0.CO;2-O 10861775 (Pubitemid 30436060)
15. Marubini E, Valsecchi MG, Analysing Survival Data from Clinical Trials and Observational Studies New York: Wiley 2004
16. Information System for Predictive Evaluation of Cancer Epidemiology and the Number of Cancer Patients in the Czech Republic. Duek L, Pavlík T, Májek O, Koptíková J, Gelnarová E, Muík J, Vyzula R, Fínek J, Czech Cancer Care in Numbers 2008-2009 Prague, Czrech Republic: Grada Publishing, Duek L, 2009 255 273
17. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020. Yabroff KR, Mariotto AB, Feuer E, Brown ML, Health Econ 2008 17 947 959 10.1002/hec.1307 17910108
18. Regression models for relative survival. Dickman PW, Sloggett A, Hills M, Hakulinen T, Stat Med 2004 23 51 64 10.1002/sim.1597 14695639 (Pubitemid 38072106)
19. Mixture models for cancer survival analysis: application to population-based data with covariates. De Angelis R, Capocaccia R, Hakulinen T, Soderman B, Verdecchia A, Stat Med 1999 18 441 454 10.1002/(SICI)1097- 0258(19990228)18:4<441::AID-SIM23>3.0.CO;2-M 10070685 (Pubitemid 29057371)
20. StataCorp, Stata Statistical Software: Release 10 College Station, TX: StataCorp LP 2008
21. Age and stage specific prevalence estimate of cancer from population based Cancer Registry using inhomogeneous Poisson process. Gras C, Daurés JP, Tretarre B, Stat Methods Med Res 2004 13 273 289 (Pubitemid 39149236)
22. Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France. Clerc L, Jooste V, Lejeune C, Schmitt B, Arveux P, Quantin C, Faivre J, Bouvier AM, Eur J Health Econ 2008 9 361 367 10.1007/s10198-007-0083-0 18030510
23. Two approaches for estimation disease prevalence from Population-based registries of incidence and total mortality. Gail MH, Kesser L, Midthune D, Scoppa S, Biometrics 1999 55 1137 1144 10.1111/j.0006-341X.1999.01137.x 11315059
24. Estimation and projection of cancer prevalence from cancer registry data. Verdecchia A, De Angelis G, Capocaccia R, Stat Med 2002 21 3511 3526 10.1002/sim.1304 12407687 (Pubitemid 35314665)
25. Predicting the lung cancer burden: accounting for selection of the patients with respect to general population mortality. Heinavaara S, Hakulinen T, Stat Med 2006 25 2967 2980 10.1002/sim.2443 16345061 (Pubitemid 44262765)
26. Estimating the prevalence of breast cancer using a disease model: data problems and trends. Kruijshaar ME, Barendregt JJ, van de Poll-Franse LV, Popul Health Metr 2003 1 5 10.1186/1478-7954-1-5 12773211 (Pubitemid 39130389)
27. Projecting cancer incidence and mortality using Bayesian age-period-cohort models. Bashir S, Estéve J, J Epidemiol Biostat 2001 6 287 296 10.1080/135952201317080698 11437093 (Pubitemid 33138819)
28. Estimating complete prevalence of cancers diagnosed in childhood. Simonetti A, Gigli A, Capocaccia R, Mariotto A, Stat Med 2008 27 990 1007 10.1002/sim.3010 17724784 (Pubitemid 351409127)
29. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Møller B, Fekjaer H, Hakulinen T, Sigvaldason H, Storm HH, Talbäck M, Haldorsen T, Stat Med 2003 22 17 2751 2766 10.1002/sim.1481 12939784 (Pubitemid 37038355)
30. Five-year survival rates of cancer patients in the Czech Republic. Pavlík T, Duek L, Májek O, aloudík J, Czech Cancer Care in Numbers 2008-2009 Czech Republic: Grada Publishing, Duek L Prague, 2009 339 376
31. NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, Køtlum JE, Olafsdáttir E, Pukkala E, Storm HH, Acta Oncol 2010 49 725 736 10.3109/02841861003782017 20491528
32. Oncologic results of laparoscopic versus conventional open surgery for stage II or III left-sided colon cancers: a randomized controlled trial. Liang JT, Huang KC, Lai HS, Lee PH, Jeng YM, Ann Surg Oncol 2007 14 109 117 17066227
33. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Masuda T, Mukoyama S, Yasuda S, Tajima T, Makuuchi H, Murayama C, Hepatogastroenterology 2003 50 1362 1366 14571738 (Pubitemid 37186484)
34. EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, et al. N Engl J Med 2006 355 1114 1123 10.1056/NEJMoa060829 16971718 (Pubitemid 44394918)
35. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, et al. J Clin Oncol 2006 24 4620 4625 10.1200/JCO.2006.06.7629 17008704 (Pubitemid 46630960)
36. Estimation of colorectal cancer prevalence in France. Colonna M, Grosclaude P, Launoy G, Tretarre B, Arveux P, Raverdy N, Benhamiche AM, Herbert C, Faivre J, Eur J Cancer 2001 37 93 96 10.1016/S0959-8049(00)00358-0 11165135 (Pubitemid 32119365)
37. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J, Br J Surg 2006 93 1115 1122 10.1002/bjs.5349 16804870 (Pubitemid 44343509)
38. Cancer incidence and mortality in the Czech Republic. Duek L, Muík J, Gelnarová E, Fínek J, Vyzula R, Abrahámová J, Klin Onkol 2010 23 311 324 21058527
39. Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012. Colonna M, Danzon A, Delafosse P, et al. Eur J Cancer 2008 44 115 122 10.1016/j.ejca.2007.10.022 18032021 (Pubitemid 350256948)
40. Czech National Cancer Screening Programmes in 2010. Májek O, Dane J, Zavoral M, Dvoák V, Suchánek S, Seifert B, et al. Klin Onkol 2010 23 343 353 21058528
41. Network of Cancer Care in the Czech Republic. Fínek J, Vyzula R, Petera J, Indrák K, trba J, Vorlíek J, Duek L, Czech Cancer Care in Numbers 2008-2009 Czech Republic: Grada Publishing, Duek L Prague, 2009 24 32